NLRP3 and neuropathy: Considering the crucial role of inflammation and oxidative stress in the development of neuropathy after PTX chemotherapy, we evaluated the impact of the pharmacological inactivation of the NLRP3 inflammasome on the expression of markers of oxidative stress, synaptic plasticity, and apoptosis.